AK
A recent study assessed whether a new tool for assessing the severity of actinic keratoses could determine a patient’s risk for developing squamous cell carcinoma.

News

News
Tuesday, December 4, 2018
A recent study assessed whether a new tool for assessing the severity of actinic keratoses could determine a patient’s risk for developing squamous cell carcinoma.
News
Wednesday, November 14, 2018
Results from a recent study showed similar efficacy and improved tolerability of a new protocol compared with conventional treatment of actinic keratoses.
News
Monday, October 22, 2018
A recent study investigated the risk for developing nonmelanoma skin cancer, including actinic keratosis, among various outdoor professions.
News
Wednesday, January 25, 2012
Ingenol mebutate (Picato) gel (0.015%, 0.05%) is the first and only topical AK therapy that can be used for as little as 2 or 3 days.

Research in Review

Research in Review
Monday, May 21, 2018
The Clinical Tips article includes suggestions for managing actinic keratoses, confirming a diagnosis of scabies, and more.
Research in Review
Tuesday, September 26, 2017
This article discusses the benefits and limitations of several new approaches using new and established field therapies for actinic keratoses.
Research in Review
Thursday, October 15, 2015
This case highlights the paramount importance of identifying and aggressively treating high-risk squamous cell carcinoma. 
Research in Review
Friday, February 3, 2012
Basal cell and squamous cell carcinomas (BCC and SCC, respectively) are the two most common forms, accounting for about 96% of non-melanoma skin cancer (NMSC). Dermatologists now have a variety of approaches that can be utilized for diagnosis, including optical coherence tomography (OCT), dermoscopy and biopsy, which remains the gold standard.